超声评估乳腺癌患者应用化疗药物后对心肌功能的影响
杨文雪 （ 佳木斯大学附属第一医院 ）
https://doi.org/10.37155/2661-4766-0402-7Abstract
化疗药物是乳腺癌患者治疗的常用手段之一，在治疗的同时也导致了心肌的损伤。化疗药物对心肌的损 伤主要表现左心室收缩功能的减低。目前除了二维超声心动图对左心室的功能评估外，斑点追踪技术及实时三维成像 技术能早期评估心肌功能损伤的。本文对超声新技术评估化疗药物所致的左心室功能损伤研究进展进行综述。
Keywords
乳腺癌；左心室功能；超声心动图Full Text
PDFReferences
[1]Herrmann J, Lenihan D, Armenian S, et al. Defining
cardiovascular toxicities of cancer therapies: an International
Cardio-Oncology Society (IC-OS) consensus statement[J].
European heart journal, 2022, 43(4): 280-299.
[2]中国抗癌协会乳腺癌专业委员会.中国抗癌协
会乳腺癌诊治指南与规范(2021年版)[J].中国癌症杂
志,2021,31(10):954-1040.DOI:10.19401/j.cnki.1007-
3639.2021.10.013.
[3]Cameli M., Mandoli G.E., Sciaccaluga C., Mondillo
S. More than 10 years of speckle tracking echocardiography:
Still a novel technique or a definite tool for clinical practice?
Echocardiography. 2019;36:958–970. doi: 10.1111/
echo.14339.
[4]Arciniegas Calle MC, Sandhu NP, Xia H, et al. Twodimensional speckle tracking echocardiography predicts
early subclinical cardiotoxicity associated with anthracyclinetrastuzumab chemotherapy in patients with breast cancer.
BMC Cancer.
[5]2018;18(1):1037. Published 2018 Oct 25. doi:10.1186/
s12885-018-4935-z
Guan J, Bao W, Xu Y, et al. Assessment of Myocardial
Work in Cancer Therapy-Related Cardiac Dysfunction
and Analysis of CTRCD Prediction by Echocardiography.
Front Pharmacol. 2021;12:770580. Published 2021 Nov 11.
doi:10.3389/fphar.2021.770580
[6]Thavendiranathan P, Liu S, Verhaert D, Calleja A,
Nitinunu A, Van Houten T, et al. Feasibility, accuracy, and
reproducibility of real-time full-volume 3D transthoracic
echocardiography to measure LV volumes and systolic
function: A fully automated endocardial contouring algorithm
in sinus rhythm and atrial fibrillation. JACC Cardiovasc
Imaging 2012; 5: 239–251.
cardiovascular toxicities of cancer therapies: an International
Cardio-Oncology Society (IC-OS) consensus statement[J].
European heart journal, 2022, 43(4): 280-299.
[2]中国抗癌协会乳腺癌专业委员会.中国抗癌协
会乳腺癌诊治指南与规范(2021年版)[J].中国癌症杂
志,2021,31(10):954-1040.DOI:10.19401/j.cnki.1007-
3639.2021.10.013.
[3]Cameli M., Mandoli G.E., Sciaccaluga C., Mondillo
S. More than 10 years of speckle tracking echocardiography:
Still a novel technique or a definite tool for clinical practice?
Echocardiography. 2019;36:958–970. doi: 10.1111/
echo.14339.
[4]Arciniegas Calle MC, Sandhu NP, Xia H, et al. Twodimensional speckle tracking echocardiography predicts
early subclinical cardiotoxicity associated with anthracyclinetrastuzumab chemotherapy in patients with breast cancer.
BMC Cancer.
[5]2018;18(1):1037. Published 2018 Oct 25. doi:10.1186/
s12885-018-4935-z
Guan J, Bao W, Xu Y, et al. Assessment of Myocardial
Work in Cancer Therapy-Related Cardiac Dysfunction
and Analysis of CTRCD Prediction by Echocardiography.
Front Pharmacol. 2021;12:770580. Published 2021 Nov 11.
doi:10.3389/fphar.2021.770580
[6]Thavendiranathan P, Liu S, Verhaert D, Calleja A,
Nitinunu A, Van Houten T, et al. Feasibility, accuracy, and
reproducibility of real-time full-volume 3D transthoracic
echocardiography to measure LV volumes and systolic
function: A fully automated endocardial contouring algorithm
in sinus rhythm and atrial fibrillation. JACC Cardiovasc
Imaging 2012; 5: 239–251.
Copyright © 2022 杨文雪
Publishing time:2022-04-30
This work is licensed under a Creative Commons Attribution 4.0 International License
Email
Location